UNITIL Corp (UTL) is Trading Lower on Unusual Volume for January 15

Equities Staff |

UNITIL Corp (UTL) experienced unusually high volume on Jan. 15, as the stock lost 2.09% to a closing price of $35.52. The stock saw 61,514 shares trade hands over the course of the day on 430 trades. Given that the stock’s average daily volume over the last month has been 40,138 shares a day, this represents a pretty substantial spike over the norm.

UNITIL Corp has a P/B ratio of 1.79. It also has a P/E ratio of 19. The stock has traded between $39.00 and $32.63 over the last 52-weeks, its 50-day SMA is now $35.33, and its 200-day SMA $34.57.

Unitil Corp is engaged in local distribution of electricity in the southeastern seacoast and state capital regions of New Hampshire and the greater Fitchburg area of north central Massachusetts and also in local distribution of natural gas.

Headquartered in Hampton, NH, UNITIL Corp has 500 employees and is currently under the leadership of CEO Robert G. Schoenberger.

For a complete fundamental analysis analysis of UNITIL Corp, check out Equities.com’s Stock Valuation Analysis report for UTL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

THE IMPORTANCE OF THE RUSSELL 3000

The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.